Pediatric Bronchiectasis Action Plan Boosts Timely Uptake of Influenza Vaccine
A bronchiectasis action management plan for children significantly improved flu vaccine uptake but not the level of unscheduled doctor visits.
A personalized bronchiectasis action management plan (BAMP) did not significantly decrease the annualized rate of nonscheduled respiratory-related doctor visits in children and adolescents, although it was associated with significant improvement in timely uptake of the influenza vaccine, researchers reported in Chest.
Researchers assessed whether children and adolescents with bronchiectasis who used a personalized, written bronchiectasis action management plan had fewer nonscheduled doctor visits than similar patients using a standard approach to care.
- The multicenter, parallel, double-blind randomized controlled trial was conducted in 3 pediatric respiratory outpatient clinics in Australia.
No quotes available in the text.
Author's summary: Personalized plan improves flu vaccine uptake in children with bronchiectasis.